Skip to main content

CIDARA IS DEVELOPING LONG-ACTING THERAPEUTICS DESIGNED TO SAVE LIVES AND IMPROVE THE STANDARD OF CARE FOR PATIENTS FACING SERIOUS DISEASES

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections.

Proprietary
Technology Platform

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit specific disease targets while simultaneously engaging the immune system.

Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases.

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections.

Proprietary
Technology Platform

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit specific disease targets while simultaneously engaging the immune system.

PIPELINE

RECENT NEWS

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121

p: (858) 752-6170
e: info@cidara.com

ABOUT

PIPELINE

REZAFUNGIN

CLOUDBREAK®

PUBLICATIONS

NEWSROOM

INVESTORS

CAREERS

Subscribe

© 2023 Cidara Therapeutics, Inc. | Terms of Use | Privacy and Cookies Policy